Viewing nowLyrica Capsule 150mg (Pregabalin)
Pregabalin 150mg
Hard capsule · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

MFDS item code 201602888 · Approved 2016.05.24 · Insurance code 693902250
Treatment of neuropathic pain, adjunctive treatment of epilepsy (partial seizures), and treatment of fibromyalgia
This medication is used for the treatment of peripheral and central neuropathic pain in adults. It is also utilized as an adjunctive treatment for partial seizures in epilepsy patients, whether or not accompanied by secondary generalization. Finally, it is effective in treating fibromyalgia. It helps improve a variety of neurological and pain-related disorders.
The total daily dose of this medicine, pregabalin, should be divided into 2 doses and administered orally with or without food. Since this medicine is primarily excreted by the kidneys, the dose should be adjusted in patients with impaired renal function. (See section ‘5. Patients with renal impairment’.) 1. Neuropathic pain 1) Peripheral neuropathic pain Adults: This medicine may be administered at an initial dose of 150 mg daily. Based on the individual patient's response and tolerability, the dose may be increased to 300 mg daily after 3 to 7 days. If necessary, it may subsequently be increased at 7-day intervals to a maximum of 600 mg daily. 2) Central neuropathic pain Adults: This medicine may be administered at an initial dose of 150 mg daily. Based on the individual patient's response and tolerability, the dose may be increased to 300 mg daily after 1 week. After an additional 1 week, it may be increased to the target daily dose of 600 mg. If the target daily dose is not tolerated, dose reduction may be considered. (See section ‘4. Discontinuation of treatment’.) 2. Epilepsy Adults: This medicine may be administered at an initial dose of 150 mg daily. Based on the individual patient's response and tolerability, the dose may be increased to 300 mg daily after 1 week. If necessary, it may subsequently be increased at 7-day intervals to a maximum of 600 mg daily. 3. Fibromyalgia The recommended dose of this medicine for fibromyalgia is 300 mg-450 mg daily. The initial dose is 75 mg twice daily (150 mg daily), and based on efficacy and tolerability, it may be increased within 1 week to 150 mg twice daily (300 mg daily). For patients who do not experience sufficient benefit at a dose of 300 mg daily, the dose may be increased within 1 week to 225 mg twice daily (450 mg daily). Clinical studies have also been conducted at a dose of 600 mg daily, but there is no evidence of additional benefit or adequate tolerability at this dose. In view of dose-dependent adverse reactions, doses exceeding 450 mg daily are not recommended. 4. Discontinuation of treatment Based on current clinical experience, if treatment with this medicine is discontinued, it should be withdrawn gradually over at least 1 week. 5. Patients with renal impairment After entering the systemic circulation, this medicine is primarily excreted unchanged by the kidneys. Clearance of this medicine is directly affected by creatinine clearance; therefore, dose reductions in patients with impaired renal function should be individualized based on creatinine clearance. Creatinine clearance [Table 1] is determined using the formula below. In patients undergoing hemodialysis, the daily dose of pregabalin should be adjusted based on renal function. In addition to the daily dose determined according to renal function, a supplemental dose should be administered promptly after each 4-hour hemodialysis session. [Table 1]. Pregabalin dosing based on renal function ≥60: Starting dose 150 mg/day, maximum dose 600 mg/day, BID or TID ≥30-<60: Starting dose 75 mg/day, maximum dose 300 mg/day, BID or TID ≥15-<30: Starting dose 25-50 mg/day, maximum dose 150 mg/day, QD or BID <15: Starting dose 25 mg/day, maximum dose 75 mg/day, QD Supplemental dose after hemodialysis: 25-100 mg, single dose b TID = total daily dose divided into 3 doses BID = total daily dose divided into 2 doses QD = administered once daily a: The total daily dose (mg/day) should be divided as specified in the dosing regimen. b: A supplemental dose is an additional dose administered as a single dose. 6. Patients with hepatic impairment Dose adjustment is not necessary in patients with hepatic impairment. 8. Elderly patients (aged 65 years and older) Dose reduction may be necessary in elderly patients with impaired renal function.
Children under 12 years of age: Use is not recommended because there are insufficient safety and efficacy data. Adolescent patients aged 12-17 years: Use is not recommended because there are insufficient safety and efficacy data.
This medication may increase the risk of suicidal thoughts or behaviors, so you should inform your healthcare provider immediately if you experience depression or mood changes while taking it. Patients with allergies to any of the ingredients in this medication or those with a genetic lactose intolerance should not take this medication. Diabetic patients should be cautious as weight gain caused by this medication may affect blood sugar control. If allergic reactions such as angioedema occur, usage should be discontinued immediately, and elderly patients should be careful to avoid falls due to dizziness or drowsiness. This medication can cause visual disturbances such as blurred vision, and you should consult your healthcare provider if symptoms appear. Suddenly stopping this medication may lead to withdrawal symptoms such as insomnia, headache, and anxiety, so you should adjust the dosage according to your healthcare provider's instructions. Patients with a history of substance abuse are at greater risk of misuse and dependency on this medication and should exercise special caution when taking it. Patients with impaired kidney function may require dose adjustments, and those with heart disease should also use this medication with caution. Taking this medication with opioids may increase central nervous system depressant effects, posing a risk of respiratory difficulties. Pregnant women should avoid this medication in early pregnancy due to the risk of fetal malformations, and women of childbearing age should use effective contraception. During breastfeeding, this medication may be passed into breast milk and affect infants, so you should discuss whether to breastfeed with your healthcare provider. Before driving or operating machinery, verify whether you experience dizziness or drowsiness after taking this medication; avoid these activities if symptoms are present. In case of overdose, symptoms such as confusion, drowsiness, and depression may occur, so avoid overdose and seek medical attention immediately if abnormalities are noted. Keep this medication out of the reach of children, and it is safer not to transfer it to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is recommended to store it at a temperature between 15°C and 30°C, avoiding extremes.
White or light yellow powder contained in a white hard capsule with a white upper and lower part
30 capsules/bottle, 60 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 150mg
Hard capsule · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.